DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
HSIC logo

Henry Schein, Inc. Stock Price

NasdaqGS:HSIC Community·US$10.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

HSIC Share Price Performance

US$0
-68.39 (-100.00%)
​
US$97.56
Fair Value
US$0
-68.39 (-100.00%)
​
Price US$0
Wed, 19 Aug 26
Fair ValueUS$97.56
Share Pricen/a

HSIC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$97.56 9.3% undervalued intrinsic discount

HSIC: Earnings Momentum From Automation And E-Commerce Will Shape Outlook

1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$110 19.5% undervalued intrinsic discount

Cloud Software And Specialty Products Will Reshape This Healthcare Distributor’s Future Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$74.46 18.9% overvalued intrinsic discount

Outsourcing And Software Adoption Will Likely Pressure Margins And Limit Earnings Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
HSIC logo
Henry Schein

Outsourcing And Software Adoption Will Likely Pressure Margins And Limit Earnings Upside

Henry Schein is leaning harder on software, automation, and outsourcing to lift profits, but those moves could backfire if dentists are slow to change how they work or if service quality slips. See why tougher pricing from big dental groups and shifts in its medical business could keep profit growth capped even if demand stays steady.Read more

View narrative
AN
AnalystLowTarget
US$74.46
18.9% overvalued intrinsic discount
AnalystLowTarget's
Fair Value
Revenue
3.61% p.a.
Profit Margin
4.21%
Future PE
13.67x
Price in 2029
US$92.14
View
HSIC logo
Henry Schein

HSIC: Earnings Momentum From Automation And E-Commerce Will Shape Outlook

Henry Schein is shifting toward higher-profit parts of its business and leaning into software, automation, and at-home care to make clinics stickier and keep growth going even in a competitive market. The upside depends on it delivering on cost cuts and new technology while navigating price pressure, staffing shortages, and changing rules abroad.Read more

View narrative
AN
AnalystConsensusTarget
US$97.56
9.3% undervalued intrinsic discount
AnalystConsensusTarget's
Fair Value
Revenue
4.19% p.a.
Profit Margin
4.3%
Future PE
17.17x
Price in 2029
US$120.04
View
HSIC logo
Henry Schein

Cloud Software And Specialty Products Will Reshape This Healthcare Distributor’s Future Earnings Power

Henry Schein is trying to become less of a plain distributor and more of a software-and-specialty products business, aiming for steadier, higher-quality profits as dental and medical practices move to cloud tools and digital workflows. The upside depends on cost-saving projects and smooth execution, while setbacks like weaker patient demand, supply pressures, or another tech disruption could slow progress.Read more

View narrative
AN
AnalystHighTarget
US$110
19.5% undervalued intrinsic discount
AnalystHighTarget's
Fair Value
Revenue
4.92% p.a.
Profit Margin
4.27%
Future PE
18.19x
Price in 2029
US$135.67
View

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
HSIC logo

Outsourcing And Software Adoption Will Likely Pressure Margins And Limit Earnings Upside

Fair Value: US$74.46 18.9% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
HSIC logo

HSIC: Q2 Execution And Cost Controls Are Expected To Support Balanced Outlook

Fair Value: US$97.56 9.3% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
HSIC logo

HSIC: Execution On Cost Actions And Buybacks Will Drive Future Upside

Fair Value: US$110 19.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with adequate balance sheet.

1 Risk
2 Rewards
View Full Analysis

Henry Schein, Inc. Key Details

US$13.6b

Revenue

US$9.3b

Cost of Revenue

US$4.3b

Gross Profit

US$3.9b

Other Expenses

US$403.0m

Earnings

Last Reported Earnings
Jun 27, 2026
Next Reporting Earnings
n/a
3.62
31.32%
2.96%
73.2%
View Full Analysis

About HSIC

Founded
1932
Employees
25000
CEO
Frederick Lowery
WebsiteView website
www.henryschein.com

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Recent HSIC News & Updates

User avatar
New Narrative • Aug 20

Outsourcing And Software Adoption Will Likely Pressure Margins And Limit Earnings Upside

Catalysts About Henry Schein Henry Schein supplies dental and medical products and technology solutions to health care practices globally. What are the underlying business or industry changes driving this perspective?
User avatar
Narrative Update • Aug 19

HSIC: Q2 Execution And Cost Controls Are Expected To Support Balanced Outlook

Henry Schein's updated analyst price target rises from about $88 to roughly $98, with analysts pointing to a strong Q2 showing, broad margin expansion, encouraging execution under the new CEO, and ongoing value creation efforts as key supports for higher revenue growth expectations and a higher future P/E assumption. Analyst Commentary Recent research on Henry Schein points to a cluster of higher price targets following the latest Q2 report, with most analysts framing the story around execution under the new CEO, margin trends, and the pace of the value creation program.
Analysis Article • Aug 12

Henry Schein's (NASDAQ:HSIC) Earnings Seem To Be Promising

Henry Schein, Inc.'s ( NASDAQ:HSIC ) recent earnings report didn't offer any surprises, with the shares unchanged over...

Recent updates

No updates

Henry Schein, Inc. Competitors

CI logo

Cigna Group

Symbol: NYSE:CI
Market cap: US$73.0b
BSX logo

Boston Scientific

Symbol: NYSE:BSX
Market cap: US$70.0b
COR logo

Cencora

Symbol: NYSE:COR
Market cap: US$61.8b
CAH logo

Cardinal Health

Symbol: NYSE:CAH
Market cap: US$54.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide